Viewing Study NCT03430518


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2025-12-26 @ 4:06 AM
Study NCT ID: NCT03430518
Status: COMPLETED
Last Update Posted: 2020-08-05
First Post: 2018-02-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
Sponsor: Amy Tiersten
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module